Transplanting Human Neural Stem Cells with ≈50% Reduction of SOX9 Gene Dosage Promotes Tissue Repair and Functional Recovery from Severe Spinal Cord Injury
Advanced Science · 2023
DOI: 10.1002/advs.202205804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2023. Verfasst von Jessica Aijia Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China. Hauptthemen laut MEDLINE: Neural Stem Cells, Spinal Cord Injuries. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong Research Grants Council General Research Fund.
Abstract (Originalsprache)
Neural stem cells (NSCs) derived from human pluripotent stem cells (hPSCs) are considered a major cell source for reconstructing damaged neural circuitry and enabling axonal regeneration. However, the microenvironment at the site of spinal cord injury (SCI) and inadequate intrinsic factors limit the therapeutic potential of transplanted NSCs. Here, it is shown that half dose of SOX9 in hPSCs‐derived NSCs (hNSCs) results in robust neuronal differentiation bias toward motor neuron lineage. The enhanced neurogenic potency is partly attributed to the reduction of glycolysis. These neurogenic and metabolic properties retain after transplantation of hNSCs with reduced SOX9 expression in a contusive SCI rat model without the need for growth factor‐enriched matrices. Importantly, the grafts exhibit excellent integration properties, predominantly differentiate into motor neurons, reduce glial scar matrix accumulation to facilitate long‐distance axon growth and neuronal connectivity with the host as well as dramatically improve locomotor and somatosensory function in recipient animals. These results demonstrate that hNSCs with half SOX9 gene dosage can overcome extrinsic and intrinsic barriers, representing a powerful therapeutic potential for transplantation treatments for SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
- Department of Neuroscience, Tat Chee Avenue, City University of Hong Kong, Hong Kong, China.
- School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China.
ORCID-Profile: Martin Cheung
Förderung
- Hong Kong Research Grants Council General Research Fund
Zitieren
APA
Liu, J. A., Tam, K. W., Chen, Y. L., Feng, X., Chan, C. W. L., Lo, A. L. H., Wu, K. L., Hui, M. N., Wu, M. H., Chan, K. K., Cheung, M. P. L., Cheung, C. W., Shum, D. K., Chan, Y. S., & Cheung, M. (2023). Transplanting Human Neural Stem Cells with ≈50% Reduction of SOX9 Gene Dosage Promotes Tissue Repair and Functional Recovery from Severe Spinal Cord Injury. Advanced Science. https://doi.org/10.1002/advs.202205804
Vancouver
Liu JA, Tam KW, Chen YL, Feng X, Chan CWL, Lo ALH, et al. Transplanting Human Neural Stem Cells with ≈50% Reduction of SOX9 Gene Dosage Promotes Tissue Repair and Functional Recovery from Severe Spinal Cord Injury. Advanced Science. 2023. doi:10.1002/advs.202205804
BibTeX
@article{Liu2023,
author = {Liu, Jessica Aijia and Tam, Kin Wai and Chen, Yong Long and Feng, Xianglan and Chan, Christy Wing Lam and Lo, Amos Lok Hang and Wu, Kenneth Lap-Kei and Hui, Man-Ning and Wu, Ming-Hoi and Chan, Ken Kwok-Keung and Cheung, May Pui Lai and Cheung, Chi Wai and Shum, Daisy Kwok-Yan and Chan, Ying-Shing and Cheung, Martin},
title = {Transplanting Human Neural Stem Cells with ≈50% Reduction of SOX9 Gene Dosage Promotes Tissue Repair and Functional Recovery from Severe Spinal Cord Injury},
journal = {Advanced Science},
year = {2023},
doi = {10.1002/advs.202205804}
}
EUVIMED